Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sadleir Laboratories was an Australian pharmaceutical company that specialized in the production of antiseptic and disinfectant solutions for clinical use. The company's flagship product, Sadleir's Solution, became a staple in Australian healthcare for surgical skin preparation and wound cleansing. These formulations typically utilize active ingredients such as chlorhexidine gluconate and cetrimide to provide broad-spectrum antimicrobial activity. Following its acquisition by Whiteley Corporation, the Sadleir's brand has continued to be a key component of the infection prevention market in the Oceania region. The company's legacy is defined by its contribution to hospital hygiene and surgical safety protocols through high-quality topical antiseptics. Today, the products are manufactured and distributed under the Whiteley umbrella, maintaining their presence in hospitals and clinics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sadleir Laboratories.